TTrialPathMatch Me to Trials
← Back to trials
RecruitingSpinal Cord InjuriesUrinary Incontinence

Sildenafil for Treatment of Urinary Incontinence in Patients With Spinal Cord Injuries

Eligible age

18–70 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The goal of this study is to determine whether administration of sildenafil will decrease urine leakage in patients with spinal cord injuries.

Sponsor: The University of Texas Medical Branch, Galveston

You may qualify if…

  • Adults with spinal cord injury (SCI), 18-75 years of age, at the time of consent
  • Have urinary incontinence (UI), with at least 3 leakage episodes/week
  • Have urodynamics assessment on file with their provider in past 3 years. If no historical data on file, subject may complete prior to study visit 1.
  • Willing and able to comply with study procedures
  • Willing and able to provide written informed consent

You may not qualify if…

  • In phone prescreen, delighted or pleased with current quality of life due to urinary symptoms.
  • Indwelling catheter
  • History of greater than 4 urinary tract infections per year
  • Multiple sclerosis
  • Significant heart, liver, kidney, pulmonary, blood, autoimmune or peripheral vascular disease
  • Systolic blood pressure \<90 or \>170, diastolic blood pressure \<50 or \>110 after repeated evaluation with proper cuff. This range is the acceptable range stated in the prescribing information for sildenafil (\>90/50 and \<170/110)
  • Active cancer
  • HIV, Hepatitis B, or Hepatitis C

Where it's recruiting

Texas

College Station · Galveston

Source: ClinicalTrials.gov · NCT04565925 · last updated 2025-12-16

Sildenafil for Treatment of Urinary Incontinence in Patients With Spin · TrialPath